Financial Analysis: Lendway (NASDAQ:LDWY) versus Yield10 Bioscience (NASDAQ:YTEN)

Lendway (NASDAQ:LDWY) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Lendway and Yield10 Bioscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lendway	N/A	-21.56%	-4.32%
Yield10 Bioscience	N/A	N/A	-296.08%

Earnings & Valuation

This table compares Lendway and Yield10 Bioscience”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lendway	$18.80 million	0.41	$2.41 million	($1.98)	-2.20
Yield10 Bioscience	$60,000.00	0.02	-$14.45 million	($26.12)	0.00

Lendway has higher revenue and earnings than Yield10 Bioscience. Lendway is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Lendway has a beta of 1.89, suggesting that its stock price is 89% more volatile than the S&P 500. Comparatively, Yield10 Bioscience has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500.

Insider and Institutional Ownership

6.6% of Lendway shares are held by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are held by institutional investors. 13.2% of Lendway shares are held by insiders. Comparatively, 6.1% of Yield10 Bioscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Lendway and Yield10 Bioscience, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lendway	0	0	0	0	0.00
Yield10 Bioscience	0	1	0	0	2.00

Summary

Lendway beats Yield10 Bioscience on 8 of the 11 factors compared between the two stocks.

About Lendway

Lendway, Inc. operates as a specialty agricultural and finance company focusing on making and managing its agricultural investments in the United States and internationally. It owns and operates FarmlandCredit.com, a non-bank lending business that seeks to purchase existing loans and/or originate and fund new loans domestically. The company was formerly known as Insignia Systems, Inc. and changed its name to Lendway, Inc. in August 2023. The company was incorporated in 1990 and is headquartered in Minneapolis, Minnesota.

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.